BioSpace News Archive

Santhera Pharmaceuticals AG (SIX: SANN) announces that it has issued 2,312,000 treasury shares.

Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that data from its Phase 4 observational registry comparing the safety and effectiveness of INOmax® (nitric oxide) gas, for inhalation, in term and near-term (TNT) neonates to that in preterm (PT) neonates with pulmonary hypertension (PH) will be presented in a poster at The Pediatric Academic Societies (PAS) 2021 Virtual Meeting

April is National Minority Health Month and the National Osteoporosis Foundation wants to continue its contribution to bridging the gap in health disparity by providing awareness and education materials to our underserved minority audiences.

AB Science SA reports its annual financials as of 31 December 2020 and provides an update on its activities.

Mayne Pharma announced results from two studies showing treatment with NEXTSTELLIS® demonstrated contraceptive efficacy and excellent cycle control across subgroups, including age, body mass index [1] and prior contraceptive use.

Leading health law firm McDermott Will & Emery is hosting its annual Physician Practice Management and ASC Symposium on May 6-7, 2021.

Phoenix Cardiac Devices, Inc., an innovator in cardiovascular medical device research and development, today presented pivotal data for its BACE™ (Basal Annuloplasty of the Cardia Externally) device, a novel modality for the treatment of Functional Mitral Regurgitation (FMR), at the virtual American Association for Thoracic Surgery (AATS) 101st annual meeting

Mechelen, Belgium;30 April 2021, 22.01 CET; regulated information –– Galapagos NV announced that its supervisory board created 2,736,250subscription rights under new subscription rightplans for the benefit of the personnelof the company and its subsidiaries.

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today it will host a conference call on May 11, 2021 at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2021.

Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced new data from its Preecludia preeclampsia rule-out test verification study are being presented today at the 2021 ACOG Annual Meeting